Psychiatry and Neurology, Neurology · Detroit, MI
NPI
1811190457
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2799 W Grand Blvd, K11/Neurology
Detroit, MI, 48202
Phone (313) 916-2835
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
699 services
Medicare patients, 2024
184
Average age 71
Drug cost, 2024
$5.6M
1,467 prescriptions
Company payments, 2025
$213
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ximena Arcila-Londono was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 112 times for 83 patients. In total Ximena Arcila-Londono billed 699 services in 33 codes, and Medicare paid $30K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 112 | 83 | $12.53 | $1,404 |
| 99215 Office E&M - Established | Facility | 83 | 57 | $100.33 | $8,328 |
| 99214 Office E&M - Established | Facility | 47 | 41 | $72.29 | $3,398 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 37 | 23 | $25.06 | $927 |
| 95886 Electrical Nerve Conductivity | Facility | 31 | 24 | $31.40 | $973 |
| 94010 Pulmonary Function Testing | Facility | 22 | 19 | $5.95 | $131 |
| 99205 Office E&M - New | Facility | 19 | 19 | $146.56 | $2,785 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $137.98 | $1,932 |
| 99215 Office E&M - Established | Office | 12 | 12 | $114.90 | $1,379 |
By year: 2022 $64K for 1,351 services; 2023 $58K for 1,153 services; 2024 $30K for 699 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ximena Arcila-Londono prescribed most often to Medicare patients was Riluzole, with 253 prescriptions and refills. In total Ximena Arcila-Londono wrote 1,467 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Riluzole Generic | 253 | 352 | 57 | $42K |
| Radicava Ors Edaravone | 253 | 253 | 31 | $3.7M |
| Gabapentin Generic | 91 | 120 | 23 | $1,109 |
| Pyridostigmine Bromide Generic | 73 | 154 | 19 | $7,594 |
| Prednisone Generic | 59 | 102 | 17 | $672 |
| Azathioprine Generic | 51 | 102 | Under 11 | $2,389 |
| Mycophenolate Mofetil Generic | 50 | 88 | 15 | $6,117 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 49 | 49 | Under 11 | $561K |
| Pregabalin Generic | 42 | 54 | Under 11 | $1,435 |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 28 | 28 | 12 | $354K |
| Citalopram Hbr Citalopram Hydrobromide | 26 | 43 | Under 11 | $126 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 26 | 26 | Under 11 | $158K |
| Nuedexta Dextromethorphan Hbr/Quinidine | 25 | 31 | Under 11 | $38K |
| Baclofen Generic | 25 | 33 | Under 11 | $579 |
| Tizanidine Hcl Generic | 22 | 29 | Under 11 | $244 |
Brand drugs: - claims; generic drugs: 1,017 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ximena Arcila-Londono $213 ($213 in general payments such as food, travel and fees) from 3 companies. The largest payer was Biogen, Inc. with $118.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.